Evaluating Risks and Benefits of SRI Prescription in Bipolar Patients

Exploring the potential benefits and risks associated with prescribing an SRI in patients with significant bipolarity, including weight gain, sexual dysfunction, severe withdrawal, rapid cycling, mixed states, and treatment resistance. The speaker shares their personal risk-benefit analysis and recommends alternative mood stabilizers such as lomotrigine. Assessing non-manic markers and using the 'mood check' questionnaire are also discussed as essential diagnostic tools.